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switch (1.08; p  0.01) and those with higher depression
scores (MADRS) experienced shorter time to switch
(0.97; p  0.02). Those receiving service through univer-
sity hospital experienced longer interval (3.19; p  0.01).
The computed hazard rate (0.68) indicates the risk of
switch is decreasing over time. CONCLUSIONS: Find-
ings indicate that symptoms and type of service delivery
site are significant in determining the switch from older
to newer agents. The shorter interval for those with
higher depression scores is expected and is probably re-
flective of clinical intervention aimed toward the amelio-
ration of negative symptoms. Interestingly, the longer
interval for those with higher side effect scores was con-
trary to expectation and may indicate that the motivating
influence to change is more related to the presentation of
primary disease state, rather than the reduction of sec-
ondary symptoms associated with the first generation
medications. The longer interval for those receiving care
in a university hospital setting is perplexing since it is
usually expected that medication adjustment will occur
during hospital stays. Further investigation of this phe-
nomenon may be aided by the inclusion of physician level
information, which is anticipated in upcoming analyses.
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OBJECTIVES: While most current antidepressant agents,
such as SSRIs and dual action agents are reasonably ef-
fective in ameliorating depressive symptomatology in
older patients, less is known about their impact on con-
current instrumental activities of daily living (IADL’s).
This study examines change in IADL’s, such as the capac-
ity to use the telephone, travel, shop, cook, do house-
work, handle money, or take medicine, from admission
to three-month post-discharge follow-up in geropsychiat-
ric patients (age 55 and older) with major depression
(ICD-9-CM codes 296.20-296.36) treated with fluoxe-
tine (n  77), mirtazapine (n  36), sertraline (n  145),
or venlaxafine (n  56). METHODS: Data were ob-
tained from the CQISM Outcomes Measurement Sys-
tem, which tracked patients admitted to geropsychiatric
inpatient programs in 111 general hospitals across 33
states between 1997–1999. IADL’s were measured by se-
lected items from the Duke OARS Multidimensional
Functional Assessment Questionnaire (Lawton & Brody,
1969). A Medication Usage Questionnaire was used to
track medications prescribed. One-way Analyses of Vari-
ance and if significant, Tukey’s pairwise comparisons
were used to compare medication groups. RESULTS: At
admission, patients exhibited moderate to severe inability
to independently carry out IADL’s (Mean score of 14 to
15 out of 21). Medication groups were indistinguishable
on change scores in overall IADL’s from time of admis-
sion to follow-up. On average, patients showed no
change in their ability to carry out IADL’s during this
time period, despite an improvement in level of depres-
sion, as measured by the collateral version of the Geriat-
ric Depression Scale (Nitcher, Burke, Roccaforte, &
Wengel, 1993). CONCLUSIONS: Antidepressant agents
in this analysis were associated with modest improve-
ment in IADL’s as assessed by the Duke OARS Multi-
demsional Functional Assessment in Older Adults. New
treatment modalities that improve IADL’s along with de-
pressive symptomatology in older patients would be ben-
eficial. Further controlled studies are needed to better un-
derstand these findings.
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OBJECTIVES: Numerous antidepressant agents are
available to treat geropsychiatric patients with depres-
sion. While most current agents are reasonably effective
in ameliorating depressive symptomatology, less is known
about the impact of these agents on concurrent maladap-
tive behaviors. This study examines change in sixteen
such behaviors from admission to discharge to three-
month post-discharge follow-up in geropsychiatric pa-
tients (age 55 and older) with major depression (ICD-9-
CM codes 296.20-296.36) treated with fluoxetine (n 
292), mirtazapine (n  288), sertraline (n  744), or ven-
laxafine (n  289). METHODS: Data were obtained
from the CQISM Outcomes Measurement System,
which tracked patients admitted to geropsychiatric inpa-
tient programs in 111 general hospitals across 33 states
between 1997–1999. Maladaptive behaviors were mea-
sured by the Psychogeriatric Dependency Rating Scale
(PGDRS) (Wilkinson & Graham-White, 1980) and a
Medication Usage Questionnaire was used to track medi-
cations prescribed at admission, discharge, and follow-
up. One-way Analyses of Variance and if significant,
Tukey’s pairwise comparisons were used to compare
medication groups. RESULTS: At admission, patients ex-
hibited mild to moderate evidence of maladaptive behav-
iors (Mean PGDRS overall score of 20 out of 48). Medi-
cation groups were indistinguishable on change scores in
overall maladaptive behaviors from time of admission to
discharge (average length of stay around 16 days), dis-
charge to follow-up, or admission to follow-up. On aver-
age, patients showed a very modest improvement (1–2
points) on the PGDRS from admission to discharge,
modest decline from discharge to follow-up (0–2 points),
